Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.
ALK Antibody (4A4), mAb, Mouse
GenScript can customize this product per customer's request including product size, buffer components, etc.
|Storage||For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.|
For more documents, please visit "Technical Support".